• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏反应中严重反应风险增加的因素:来自欧洲过敏登记处的数据分析。

Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry.

机构信息

Department of Dermatology and Allergology, Charite-Universitätsmedizin Berlin, Berlin, Germany.

Allergy Vigilance Network, University Hospital Nancy, Nancy, France.

出版信息

Allergy. 2018 Jun;73(6):1322-1330. doi: 10.1111/all.13380. Epub 2018 Mar 8.

DOI:10.1111/all.13380
PMID:29318637
Abstract

BACKGROUND

Preventive measures to decrease the frequency and intensity of anaphylactic events are essential to provide optimal care for allergic patients. Aggravating factors may trigger or increase the severity of anaphylaxis and therefore need to be recognized and avoided.

OBJECTIVE

To identify and prioritize factors associated with an increased risk of developing severe anaphylaxis.

METHODS

Data from the Anaphylaxis Registry (122 centers in 11 European countries) were used in logistic regression models considering existing severity grading systems, elicitors, and symptoms to identify the relative risk of factors on the severity of anaphylaxis.

RESULTS

We identified higher age and concomitant mastocytosis (OR: 3.1, CI: 2.6-3.7) as the most important predictors for an increased risk of severe anaphylaxis. Vigorous physical exercise (OR: 1.5, CI: 1.3-1.7), male sex (OR: 1.2, CI: 1.1-1.3), and psychological burden (OR: 1.4, CI: 1.2-1.6) were more often associated with severe reactions. Additionally, intake of beta-blockers (OR: 1.9, CI: 1.5-2.2) and ACE-I (OR: 1.28, CI: 1.05, 1.51) in temporal proximity to allergen exposition was identified as an important factor in logistic regression analysis.

CONCLUSION

Our data suggest it may be possible to identify patients who require intensified preventive measures due to their relatively higher risk for severe anaphylaxis by considering endogenous and exogenous factors.

摘要

背景

预防措施可降低过敏患者发生过敏反应的频率和严重程度,从而为过敏患者提供最佳护理。诱发因素可能会引发或加重过敏反应,因此需要识别并避免。

目的

确定并确定与严重过敏反应风险增加相关的因素,并对这些因素进行优先级排序。

方法

使用来自过敏反应登记处(欧洲 11 个国家的 122 个中心)的数据,在考虑到现有严重程度分级系统、过敏原和症状的逻辑回归模型中,确定了对过敏反应严重程度具有相对风险的因素。

结果

我们发现,年龄较大和同时患有肥大细胞增多症(OR:3.1,CI:2.6-3.7)是严重过敏反应风险增加的最重要预测因素。剧烈的体力活动(OR:1.5,CI:1.3-1.7)、男性(OR:1.2,CI:1.1-1.3)和心理负担(OR:1.4,CI:1.2-1.6)与严重反应更相关。此外,在过敏原暴露的时间范围内,β受体阻滞剂(OR:1.9,CI:1.5-2.2)和 ACE-I(OR:1.28,CI:1.05,1.51)的摄入也被确定为逻辑回归分析中的一个重要因素。

结论

我们的数据表明,通过考虑内源性和外源性因素,可能有可能确定因相对较高的严重过敏反应风险而需要强化预防措施的患者。

相似文献

1
Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry.过敏反应中严重反应风险增加的因素:来自欧洲过敏登记处的数据分析。
Allergy. 2018 Jun;73(6):1322-1330. doi: 10.1111/all.13380. Epub 2018 Mar 8.
2
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry.老年患者的过敏反应——来自欧洲过敏反应登记处的数据。
Front Immunol. 2019 Apr 24;10:750. doi: 10.3389/fimmu.2019.00750. eCollection 2019.
3
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.系统性肥大细胞增多症患者中过敏反应的高患病率——单中心经验
Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.
4
[Food-induced anaphylaxis - data from the anaphylaxis registry].[食物诱发的过敏反应——来自过敏反应登记处的数据]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jul;59(7):836-40. doi: 10.1007/s00103-016-2365-0.
5
Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics.致命性和近乎致命性过敏反应:来自欧洲过敏登记处和国家健康统计数据。
J Allergy Clin Immunol Pract. 2024 Jan;12(1):96-105.e8. doi: 10.1016/j.jaip.2023.09.044. Epub 2023 Oct 9.
6
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry.变应性反应患者的二级预防措施:来自变应性反应登记处的数据。
Allergy. 2020 Apr;75(4):901-910. doi: 10.1111/all.14069. Epub 2019 Oct 21.
7
Refractory Anaphylaxis: Data From the European Anaphylaxis Registry.难治性过敏反应:来自欧洲过敏登记处的数据。
Front Immunol. 2019 Oct 18;10:2482. doi: 10.3389/fimmu.2019.02482. eCollection 2019.
8
[Epidemiology of anaphylaxis].[过敏反应的流行病学]
Hautarzt. 2013 Feb;64(2):88-92. doi: 10.1007/s00105-012-2449-1.
9
Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.膜翅目毒液免疫疗法临床疗效的预测因素。
Clin Exp Allergy. 2014;44(5):736-46. doi: 10.1111/cea.12275.
10
First European data from the network of severe allergic reactions (NORA).来自严重过敏反应网络(NORA)的首批欧洲数据。
Allergy. 2014 Oct;69(10):1397-404. doi: 10.1111/all.12475. Epub 2014 Aug 16.

引用本文的文献

1
IgE and non-IgE-mediated pathways in anaphylaxis.过敏反应中的IgE和非IgE介导途径。
Semin Immunopathol. 2025 Aug 13;47(1):34. doi: 10.1007/s00281-025-01056-7.
2
Lactate in Anaphylaxis: 100 Years On.过敏反应中的乳酸:百年回顾。
Sports Med. 2025 Jul 24. doi: 10.1007/s40279-025-02273-8.
3
Emergency Monitoring Following A Diagnosis of Anaphylaxis.过敏反应诊断后的紧急监测
Curr Allergy Asthma Rep. 2025 Jul 8;25(1):29. doi: 10.1007/s11882-025-01210-z.
4
Severe drug-associated anaphylaxis: a complementary descriptive analyses of registry cases and spontaneous reports.严重药物相关性过敏反应:登记病例与自发报告的补充描述性分析
Eur J Clin Pharmacol. 2025 Jun 27. doi: 10.1007/s00228-025-03868-w.
5
Risk factors/cofactors for heightened anaphylaxis severity in Japanese adults: A 10-year single-center retrospective cohort study.日本成年人中过敏反应严重程度增加的风险因素/辅助因素:一项为期10年的单中心回顾性队列研究。
World Allergy Organ J. 2025 May 8;18(6):101062. doi: 10.1016/j.waojou.2025.101062. eCollection 2025 Jun.
6
Characteristics and Outcomes of Anaphylaxis in Emergency Department Visits Among Older Adults.老年人急诊科就诊时过敏反应的特征与结局
J Allergy Clin Immunol Pract. 2025 Aug;13(8):2014-2024.e4. doi: 10.1016/j.jaip.2025.04.023. Epub 2025 Apr 22.
7
Understanding and Managing Infusion Reactions and Hypophosphataemia With Intravenous Iron-A Nurses' Consensus Paper.《理解与处理静脉补铁引起的输液反应和低磷血症——护士共识文件》
Nurs Open. 2025 Apr;12(4):e70191. doi: 10.1002/nop2.70191.
8
Linear regression reporting practices for health researchers, a cross-sectional meta-research study.健康研究人员的线性回归报告实践:一项横断面元研究
PLoS One. 2025 Mar 20;20(3):e0305150. doi: 10.1371/journal.pone.0305150. eCollection 2025.
9
Exploring the anti-anaphylaxis potential of natural products: A Review.探索天然产物的抗过敏潜力:综述
Inflammopharmacology. 2025 Mar 19. doi: 10.1007/s10787-025-01685-2.
10
Recent findings from the anaphylaxis registry: Where are we, where do we want to go?过敏反应登记处的最新发现:我们现在何处,又想去何方?
Allergol Select. 2025 Mar 6;9:21-27. doi: 10.5414/ALX02529E. eCollection 2025.